ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH IMPROVEMENTS IN CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MIRIKIZUMAB

Marla C. Dubinsky  ¹     Remo Panaccione  ²     James D. Lewis  ³     Bruce E. Sands  ³     Toshifumi Hibi  ⁴     Scott Lee  ⁵     April Naegeli  ⁶     Mingyang Shan  ⁶     Lilly Immunology Publications  ⁶     Nathan Morris  ⁶     Vipin Arora  ⁶     Alison Potts Bleakman  ⁶     Ruth Belin  ⁶     Simon Travis  ^7    
1 Icahn School of Medicine at Mount Sinai, New York, United States
² University of Calgary, Calgary, Canada
³ University of Pennsylvania, Philadelphia, United States
⁴ Kitasato Institute Hospital Center for Advanced IBD Research and Treatment, Tokyo, Japan
⁵ University of Washington Medical Center, Seattle, United States
⁶ Eli Lilly and Company, Indianapolis, United States
⁷ Oxford University Hospital, Oxford, United Kingdom

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)